Stockreport

Are IRadimed Corporation (NASDAQ:IRMD) Investors Paying Above The Intrinsic Value? [Yahoo! Finance]

iRadimed Corporation  (IRMD) 
Last iradimed corporation earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: iradimed.com/en-us/investors/investor-contact
PDF IRadimed is estimated to be 31% overvalued based on current share price of US$47.57 IRadimed's peers seem to be trading at a lower premium to fair value based on the [Read more]